Real-World Treatment Patterns and Patient reported outcome in COPD (REMIND)A secondary database study using COPD cohort study in Japan to investigate health status of COPD patients with different inhaler treatment
Not Applicable
- Conditions
- COPD
- Registration Number
- JPRN-jRCT1030230176
- Lead Sponsor
- Tashiro Naoki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 448
Inclusion Criteria
1)Patients taken with any of following inhaler treatments ( LAMA, LAMA+LABA(both single and dual inhaler) or ICS+LABA(both single and dual inhaler) at cohort entry)
Exclusion Criteria
1)Patients enrolled at the sites participated in the COPD cohort study where not agreed on secondary use of data for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Proportion of patients with CAT (>=10, <10) in each inhaler treatment group at cohort entry
- Secondary Outcome Measures
Name Time Method 1-1)Proportion of patients with changes of inhaler treatment categories (step up or all other categories) during 1 year follow-up period by patients with CAT (>=10, <10) in each inhaler treatment group at cohort entry<br>1-2) Proportion of patients with all patterns of inhaler treatment category changes during 1 year follow-up period by patients with CAT (>=10, <10) in each inhaler treatment group at cohort entry<br>2) Proportion of patients with CAT (>=10, <10) at 1 year follow-up by patients with CAT (>=10, <10) in each inhaler treatment group at cohort entry<br>3) Mean change in the CAT scores between cohort entry and 1 year follow-up in each inhaler treatment group (LAMA, LAMA+LABA or ICS+LABA) at cohort entry